These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 8531111

  • 1. The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes.
    Bencherif M, Eisenhour CM, Prince RJ, Lippiello PM, Lukas RJ.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1418-26. PubMed ID: 8531111
    [Abstract] [Full Text] [Related]

  • 2. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
    Sun H, McCardy EA, Machu TK, Blanton MP.
    J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
    [Abstract] [Full Text] [Related]

  • 3. Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380.
    Mogg AJ, Jones FA, Pullar IA, Sharples CG, Wonnacott S.
    Neuropharmacology; 2004 Nov; 47(6):848-59. PubMed ID: 15527819
    [Abstract] [Full Text] [Related]

  • 4. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
    Sacaan AI, Reid RT, Santori EM, Adams P, Correa LD, Mahaffy LS, Bleicher L, Cosford ND, Stauderman KA, McDonald IA, Rao TS, Lloyd GK.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
    [Abstract] [Full Text] [Related]

  • 6. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.
    Fryer JD, Lukas RJ.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):88-92. PubMed ID: 9862757
    [Abstract] [Full Text] [Related]

  • 7. Effect of anabasine on catecholamine secretion from the perfused rat adrenal medulla.
    Hong SP, Jeong MG, Lim DY.
    J Cardiol; 2007 Dec; 50(6):351-62. PubMed ID: 18186309
    [Abstract] [Full Text] [Related]

  • 8. Differential coupling of alpha7 and non-alpha7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cells.
    Dickinson JA, Hanrott KE, Mok MH, Kew JN, Wonnacott S.
    J Neurochem; 2007 Feb; 100(4):1089-96. PubMed ID: 17181555
    [Abstract] [Full Text] [Related]

  • 9. Glycine blocks the increase in intracellular free Ca2+ due to vasoactive mediators in hepatic parenchymal cells.
    Qu W, Ikejima K, Zhong Z, Waalkes MP, Thurman RG.
    Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1249-56. PubMed ID: 12388211
    [Abstract] [Full Text] [Related]

  • 10. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment.
    Ke L, Eisenhour CM, Bencherif M, Lukas RJ.
    J Pharmacol Exp Ther; 1998 Aug; 286(2):825-40. PubMed ID: 9694939
    [Abstract] [Full Text] [Related]

  • 11. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
    Lukas RJ, Audhya T, Goldstein G, Lucero L.
    Mol Pharmacol; 1990 Dec; 38(6):887-94. PubMed ID: 1701215
    [Abstract] [Full Text] [Related]

  • 12. Strychnine: a potent competitive antagonist of alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal neurons.
    Matsubayashi H, Alkondon M, Pereira EF, Swanson KL, Albuquerque EX.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):904-13. PubMed ID: 9495848
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of 8-(N,N-diethylamino)-n-octyl-3,4,5-trimethoxybenzoate (TMB-8) on intracellular Ca2+ elevated by neurotransmitters in brain cells.
    Zhang XQ, Wang B, Zhang MY, Xiao JG.
    Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):893-6. PubMed ID: 11270987
    [Abstract] [Full Text] [Related]

  • 14. A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate in mice.
    Welch SP, Dewey WL.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):320-6. PubMed ID: 3095536
    [Abstract] [Full Text] [Related]

  • 15. Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist.
    Chiara DC, Trinidad JC, Wang D, Ziebell MR, Sullivan D, Cohen JB.
    Biochemistry; 2003 Jan 21; 42(2):271-83. PubMed ID: 12525154
    [Abstract] [Full Text] [Related]

  • 16. Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes.
    Gentry CL, Lukas RJ.
    J Pharmacol Exp Ther; 2001 Dec 21; 299(3):1038-48. PubMed ID: 11714893
    [Abstract] [Full Text] [Related]

  • 17. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs.
    Xiao Y, Smith RD, Caruso FS, Kellar KJ.
    J Pharmacol Exp Ther; 2001 Oct 21; 299(1):366-71. PubMed ID: 11561100
    [Abstract] [Full Text] [Related]

  • 18. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
    Lodge NJ, Halaka NN.
    J Pharmacol Exp Ther; 1993 Jun 21; 265(3):1399-405. PubMed ID: 8510016
    [Abstract] [Full Text] [Related]

  • 19. RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.
    Bencherif M, Lovette ME, Fowler KW, Arrington S, Reeves L, Caldwell WS, Lippiello PM.
    J Pharmacol Exp Ther; 1996 Dec 21; 279(3):1413-21. PubMed ID: 8968366
    [Abstract] [Full Text] [Related]

  • 20. Differential inhibition of catecholamine secretion by amitriptyline through blockage of nicotinic receptors, sodium channels, and calcium channels in bovine adrenal chromaffin cells.
    Park TJ, Shin SY, Suh BC, Suh EK, Lee IS, Kim YS, Kim KT.
    Synapse; 1998 Jul 21; 29(3):248-56. PubMed ID: 9635895
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.